Susquehanna International Group, LLP Graybug Vision, Inc. Transaction History

Susquehanna International Group, LLP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$0.46 - $1.05 $8,455 - $19,300	-18,381 Reduced 29.07%	44,860 $22,000
Q3 2022 Nov 14, 2022	BUY	$0.93 - $1.18 $48,371 - $61,374	52,012 Added 463.19%	63,241 $59,000
Q2 2022 Aug 15, 2022	SELL	$0.76 - $1.25 $28,693 - $47,193	-37,755 Reduced 77.08%	11,229 $12,000
Q3 2021 Nov 15, 2021	SELL	$3.18 - $5.17 $698,960 - $1.14 Million	-219,799 Reduced 81.78%	48,984 $162,000
Q2 2021 Aug 11, 2021	BUY	$3.53 - $6.1 $948,803 - $1.64 Million	268,783 New	268,783 $1.46 Million

Ticker GRAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,517,700
Market Cap $63.5M
Description
Graybug Vision, Inc., a clinical-stage biopharmaceutical company, focuses on the development of medicines for the treatment of diseases of the retina and optic nerve. The company's lead product candidate is GB-102, an intravitreal injection of a microparticle depot formulation of sunitinib that is in Phase I/IIa and IIb clinical trials for the t...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.